I wrote about a really important book, Invisible Women, and its topic—the sex-biased data gaps that undermine virtually all decision-making in the world. Perhaps nowhere more pernicious than in healthcare. Please have a read and tell me what you think.
linkedin.com/pulse/confronti…
This Post is from an account that no longer exists. Learn more
I am thrilled to share Genialis closed our #SeriesA financing. We’ve been working our tails off for years to build what I believe will be one of the most influential technology platforms in #precisionmedicine. Thanks to our stellar team and expert investor syndicate! #PeopleFirst
This Post is from an account that no longer exists. Learn more
Not only is Anže a baller bioinf., he's a super good guy. Even though he can out jump me by a good half meter, he let me score in beach volleyball on a recent team retreat. But seriously, he's got the kind of talent needed to solve some of the toughest challenges in biomedicine!
This Post is from an account that no longer exists. Learn more
Today Genialis announced the beginning of a campaign to grow our exceptional team. Please check out our open job postings, and watch this space for future announcements.
This Post is from an account that no longer exists. Learn more
Rafael Rosengarten retweeted
The @theaaih is leading the thought leadership on this topic with work in its regulatory working group focused on digitizing the IND
@rafecooks @PaulHowardNYC @charleskfisher @Angeli_Moeller
.@SusannaLHarris and I had a great conversation about the importance of communication at all levels in science, including and especially in building communities to tackle #raredisease ... Have a listen, post a comment!
This Post is from an account that no longer exists. Learn more
One of the most eye-opening conversations I've had in this business. Many thanks to @aloktayi of @VibeBio, poised to change the way we develop medicines for rare disease through #DAO 's and community engagement. Have a listen! #talkingprecisionmedicine podcast
This Post is from an account that no longer exists. Learn more
If the question is build v buy, ask yourself if there’s already a great of the shelf solution. Genialis’ software platforms provide world class data science infrastructure to for biomedical discovery!
This Post is from an account that no longer exists. Learn more
Rafael Rosengarten retweeted
AI is not hype. It works, and we need more of it. We're not here to make incremental changes in healthcare. We're here to revolutionize healthcare.
@rafecooks CEO @Genialis
What a great audience today to discuss best practices in applying #MachineLearning for #precisionmedicine !
This Post is from an account that no longer exists. Learn more
So exciting to be back again this year. Four years ago at this very @BioTechX_ conference, the idea for @theaaih was galvanized!
And it’s on! @BioTechX_ 2022 is now open with #AAIH executive committee member Najat Khan delivering the plenary keynote address. Join us in the Montreal room!
A wonderfully full week ahead at @BioTechX_ 2022. Come see my talk tomorrow and the @theaaih panel Weds!
This Post is from an account that no longer exists. Learn more
En route to Basel for @BioTechX_ 2022. Hit me up if you’re in town! Excited to discuss the role of #MachineLearning in #precisionmedicine
This Post is from an account that no longer exists. Learn more
What an amazing #teambuilding adventure! @Genialis we aim to build a great company for the world of #precisionmedicine and also a great company for our employees and team members! Get outdoors and move!
This Post is from an account that no longer exists. Learn more
Rafael Rosengarten retweeted
Congrats to my former @Harvard bandmate @CarolynBertozzi on her @NobelPrize in chemistry! We won the Ivy League Battle of the Bands in 1986 with our rockin’ group ‘Bored Of Education’, with her on keyboards & me in spandex. news.stanford.edu/2022/10/05…
Rafael Rosengarten retweeted
A rare encounter with a giant phantom jellyfish 990m (3,200 ft) beneath the surface in Monterey Bay.
Rafael Rosengarten retweeted
Our latest research has just been published today in the journal Nature. We engineered yeast to produce the cancer therapeutic vinblastine. You can find the work here: nature.com/articles/s41586-0…. It is the longest biosynthetic pathway ever refactored into yeast.
Great to catch up with so many wonderful colleagues, many of whom I’d only met via Zoom until this week.
#AAIH is having a blast at #PMWC22 with great people and great discussions from @ASCOCancerLinQ, @RecursionPharma, @Genialis, @InSilicoMeds, @biosymetrics, and @JanssenGlobal!
